Radiation Dose Management Market

Market Insights

The radiation dose management market is expected to reach US$ 1,349.5 million by 2027, up from US$ 179.0 million in 2018, with a compounded annual growth rate (CAGR) of 25.8% from 2019 to 2027.

The rising prevalence of chronic disease and stringent regulatory norms related to the safety of radiation exposure in patients are the major drivers associated with the radiation dose management market. A significant rise in diagnostic screening centers and rising public health awareness further propel the radiation dose management market.

Market Synopsis

The ability to design a robust radiation safety program and the efficient collection of clinical data pertaining to patient disease screening increased the demand for software solutions.

In the present scenario, software solutions are spearheading the solution segment for the radiation dose management market. Prominent features associated with them, such as the capability to design a robust radiation safety program ensuring negligible side effects in patients exposed to radiation therapy, increase the demand for software solutions.

Efficient collection of clinical data pertaining to patient disease diagnosis further propels market growth for software solutions. Services are keen to register steady growth in the near future owing to rising public health awareness resulting in early disease diagnosis and a significant rise in diagnostic centers worldwide.

Ease of operation, effective radiation dose monitoring, and quick acquisition of precise images increase the popularity of computed tomography over other modalities.

Computed tomography is currently leading the modality segment for the radiation dose management market. The inherent characteristics of computed tomography include the elimination of overlapping structures, which makes the internal anatomy more apparent and visible. It guides the surgeons during critical surgical procedures; ease of operation, effective radiation dose monitoring, and quick turnaround time are the key attributes that increase its popularity over other modalities.

Nuclear medicine scans have received a lot of attention in the last decade because of their ability to understand cellular metabolism in chronic disease and to thoroughly investigate a tumor or infection and its spread throughout the body. It is a useful tool to validate whether the ongoing treatment protocol is effective or needs change.

Strong regulatory norms regarding patient safety receiving radiation therapy and the rising prevalence of chronic disease drive market growth in North America.

North America holds the largest market share of 36% in the regional segment of the radiation dose management market. The chief parameters consolidating its market growth in North America are stringent norms imposed by healthcare agencies on patients receiving radiation therapy and the rising prevalence of chronic disease, which results in early disease diagnosis.

Favorable reimbursement scenarios pertaining to the utilization of radiation dose therapy further bolster the market’s growth in the region. Europe represents 29.5% of the market share and is the second largest regional market owing to the domicile of key players such as Bayer AG, Philips Healthcare, Sectra AB, etc., which promote the market performance of radiation dose management. Asia Pacific, with a market share of 22%, is keen to register outstanding growth over the forecast period on account of developing healthcare infrastructure and increasing medical tourism.

Periods of History and Forecast

This research report presents the analysis of each segment from 2017 to 2027, considering 2018 as the base year for the research. The compound annual growth rate (CAGR) for each of the respective segments is calculated for the forecast period from 2019 to 2027.

Report Scope by Segments

The market segmentation for the scope of the report is done by solution, modality, and geography.

Medical device manufacturers specializing in radiation dose management solutions are Bayer AG, Fujifilm Holdings Corporation, Bracco Imaging S.P.A., G.E. Healthcare, Philips Healthcare, Medsquare, Novarad Corporation, Sectra AB, Pacshealth, L.L.C., Qaelum N.V.

Key questions are answered in this report.

• Which major medical device manufacturers are providing radiation dose management solutions?
• What are the latest acquisitions and mergers taking place in the radiation dose management market?
• What are the regulatory guidelines sanctioned for the safety of radiation therapy?
• Which factors promote the software solutions market’s growth?
• What are the underlying principle behind nuclear medicine scans and their use in disease diagnosis and treatment validation?
• Which parameters are responsible for the market dominance of the North American regional segment in the radiation dose management market?

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global RDM Market Portraiture
2.2. Global RDM Market, by Solution, 2018 (US$ Mn)
2.3. Global RDM Market, by Modality, 2018 (US$ Mn)
2.4. Global RDM Market, by Geography, 2018 (US$ Mn)

Chapter 3. Radiation Dose Management (RDM) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2018
3.6. Competitive Analysis: Global RDM Market, by Key Players, 2018

Chapter 4. Global Radiation Dose Management (RDM) Market, by Solution
4.1. Overview
4.2. Software
4.3. Services

Chapter 5. Global Radiation Dose Management (RDM) Market, by Modality
5.1. Overview
5.2. Radiography
5.3. Computed Tomography
5.4. Mammography
5.5. Fluoroscopy & Interventional Imaging
5.6. Nuclear Medicine Scans
5.7. Others

Chapter 6. Global Radiation Dose Management (RDM) Market, by Geography
6.1. Overview
6.2. North America RDM Market Analysis, 2017 – 2027
6.2.1. North America RDM Market, by Solution, 2017 – 2027 (US$ Mn)
6.2.2. North America RDM Market, by Modality, 2017 – 2027 (US$ Mn)
6.2.3. North America RDM Market, by Country, 2017 – 2027 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe RDM Market Analysis, 2017 – 2027
6.3.1. Europe RDM Market, by Solution, 2017 – 2027 (US$ Mn)
6.3.2. Europe RDM Market, by Modality, 2017 – 2027 (US$ Mn)
6.3.3. Europe RDM Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific RDM Market Analysis, 2017 – 2027
6.4.1. Asia Pacific RDM Market, by Solution, 2017 – 2027 (US$ Mn)
6.4.2. Asia Pacific RDM Market, by Modality, 2017 – 2027 (US$ Mn)
6.4.3. Asia Pacific RDM Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America RDM Market Analysis, 2017– 2027
6.5.1. Latin America RDM Market, by Solution, 2017 – 2027 (US$ Mn)
6.5.2. Latin America RDM Market, by Modality, 2017 – 2027 (US$ Mn)
6.5.3. Latin America RDM Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East and Africa RDM Market Analysis, 2017 – 2027
6.6.1. MEA RDM Market, by Solution, 2017 – 2027 (US$ Mn)
6.6.2. MEA RDM Market, by Modality, 2017 – 2027 (US$ Mn)
6.6.3. MEA RDM Market, by Country/Region, 2017 – 2027 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Bayer AG
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Bracco Imaging S.P.A.
7.3. Fujifilm Holdings Corporation
7.4. GE Healthcare
7.5. Medsquare
7.6. Novarad Corporation
7.7. Pacshealth, LLC.
7.8. Philips Healthcare
7.9. Qaelum N.V.
7.10. Sectra AB

List of Figures

FIG. 1 Radiation Dose Management (RDM) Market: Research Methodology
FIG. 2 RDM: Market Segmentation
FIG. 3 Global RDM Market, by Solution, 2018 (US$ Mn)
FIG. 4 Global RDM Market, by Modality, 2018 (US$ Mn)
FIG. 5 Global RDM Market, by Geography, 2018 (US$ Mn)
FIG. 6 Attractive Investment Proposition: by Geography, 2018
FIG. 7 Competitive Analysis: Global RDM Market, by Key Players, 2018
FIG. 8 Global Software Solution Market for RDM, 2017 – 2027 (US$ Mn)
FIG. 9 Global Services Solution Market for RDM, 2017 – 2027 (US$ Mn)
FIG. 10 Global Radiography Market for RDM, 2017 – 2027 (US$ Mn)
FIG. 11 Global Computed Tomography Market for RDM, 2017 – 2027 (US$ Mn)
FIG. 12 Global Mammography Market for RDM, 2017 – 2027 (US$ Mn)
FIG. 13 Global Fluoroscopy & Interventional Imaging Market for RDM, 2017 – 2027 (US$ Mn)
FIG. 14 Global Nuclear Medicine Scans Market for RDM, 2017 – 2027 (US$ Mn)
FIG. 15 Global Other Modality Market for RDM, 2017 – 2027 (US$ Mn)
FIG. 16 U.S. RDM Market, 2017 – 2027 (US$ Mn)
FIG. 17 Canada RDM Market, 2017 – 2027 (US$ Mn)
FIG. 18 U.K. RDM Market, 2017 – 2027 (US$ Mn)
FIG. 19 Germany RDM Market, 2017 – 2027 (US$ Mn)
FIG. 20 Rest of Europe RDM Market, 2017 – 2027 (US$ Mn)
FIG. 21 China RDM Market, 2017 – 2027 (US$ Mn)
FIG. 22 Japan RDM Market, 2017 – 2027 (US$ Mn)
FIG. 23 Rest of Asia Pacific RDM Market, 2017 – 2027 (US$ Mn)
FIG. 24 Brazil RDM Market, 2017 – 2027 (US$ Mn)
FIG. 25 Mexico RDM Market, 2017 – 2027 (US$ Mn)
FIG. 26 Rest of Latin America RDM Market, 2017 – 2027 (US$ Mn)
FIG. 27 GCC RDM Market, 2017 – 2027 (US$ Mn)
FIG. 28 Rest of MEA RDM Market, 2017 – 2027 (US$ Mn)

List of Tables

TABLE 1 Global Radiation Dose Management (RDM) Market Portraiture
TABLE 2 Global RDM Market, by Solution, 2017 – 2027 (US$ Mn)
TABLE 3 Global RDM Market , by Modality, 2017 – 2027 (US$ Mn)
TABLE 4 Global RDM Market, by Geography, 2017 – 2027 (US$ Mn)
TABLE 5 North America RDM Market, by Solution, 2017 – 2027 (US$ Mn)
TABLE 6 North America RDM Market, by Modality, 2017 – 2027 (US$ Mn)
TABLE 7 North America RDM Market, by Country, 2017 – 2027 (US$ Mn)
TABLE 8 Europe RDM Market, by Solution, 2017 – 2027 (US$ Mn)
TABLE 9 Europe RDM Market, by Modality, 2017 – 2027 (US$ Mn)
TABLE 10 Europe RDM Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 11 Asia Pacific RDM Market, by Solution, 2017 – 2027 (US$ Mn)
TABLE 12 Asia Pacific RDM Market, by Modality, 2017 – 2027 US$ Mn)
TABLE 13 Asia Pacific RDM Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 14 Latin America RDM Market, by Solution, 2017 – 2027 (US$ Mn)
TABLE 15 Latin America RDM Market, by Modality, 2017 – 2027 (US$ Mn)
TABLE 16 Latin America RDM Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 17 Middle East and Africa RDM Market, by Solution, 2017 – 2027 (US$ Mn)
TABLE 18 Middle East and Africa RDM Market, by Modality, 2017 – 2027 (US$ Mn)
TABLE 19 Middle East and Africa RDM Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 20 Bayer AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Bracco Imaging S.P.A.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Fujifilm Holdings Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 GE Healthcare: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Medsquare: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Novarad Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 Pacshealth, LLC.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Philips Healthcare: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 Qaelum N.V.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Sectra AB: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)